What is new in primary biliary cirrhosis?

Digestive Diseases

Volumn 30, Issue SUPPL. 1, 2012, Pages 20-31

  Bogdanos, Dimitrios P ^a   Gershwin, M Eric ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Autoimmunity; Bile ducts; Cholestasis; Immunology; Liver; Rheumatology

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CIGARETTE SMOKE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOCHONDRION ANTIBODY; SERUM ALBUMIN; STAT4 PROTEIN; XENOBIOTIC AGENT;

AGING; ARTICLE; AUTOPHAGY; BILE DUCT DISEASE; CHOLECYSTECTOMY; CHOLESTASIS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ELASTOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FIBROSIS; GENETIC ASSOCIATION; HAPLOTYPE; HLA SYSTEM; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; IMMUNOPATHOGENESIS; INCIDENCE; INFECTION; INNATE IMMUNITY; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERIPHERAL LYMPHOCYTE; PLASMA CELL; POLYPECTOMY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; RISK FACTOR; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TELOMERE HOMEOSTASIS; TH17 CELL; THYROID DISEASE; TONSILLECTOMY; UNITED KINGDOM; UNITED STATES; URINARY TRACT INFECTION; X LINKED SEVERE COMBINED IMMUNODEFICIENCY;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; RISK FACTORS; SMOKING; TELOMERE HOMEOSTASIS;

EID: 84867701500     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000341118     Document Type: Article

References (67)

1. Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273. (Pubitemid 41345948)
2. Gershwin ME, Mackay IR: The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 2008; 47: 737-745. (Pubitemid 351280742)
3. Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME: Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 2010; 26: 274-279.
4. Bogdanos DP, Baum H, Vergani D: Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7: 759-777, vi. (Pubitemid 37229503)
5. Bogdanos DP, Komorowski L: Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta 2011; 412: 502-512.
6. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF: Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-1402. (Pubitemid 26395233)
7. van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL: The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988; 167: 1791-1799.
8. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H: Antigp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007; 45: 118-127. (Pubitemid 46144371)
9. Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D: Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005; 54: 528-532. (Pubitemid 40395506)
10. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, Invernizzi P: Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006; 43: 1135-1144. (Pubitemid 43724638)
11. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ: Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
12. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J, Prieto J, Rust C, Geenes VL, Williamson C, Moolenaar WH, Beuers U, Oude Elferink RP: Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139: 1008-1018, 1018.e1.
13. Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME: Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010; 7: 1-10.
14. Boonstra K, Beuers U, Ponsioen CY: Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review. J Hepatol 2012; 56: 1181-1188.
15. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D: Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 2008; 14: 3374-3387.
16. Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME: Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24: 97-103. (Pubitemid 26249419)
17. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote EJ, Hirschfield GM, Tan EM, Miyachi K, Bignotto M, Battezzati PM, Lleo A, Leung PS, Podda M, Gershwin ME, Invernizzi P: PBC screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010; 35: 436-442.
18. Dahnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, Stocker W, Komorowski L: New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem 2009; 55: 978-985.
19. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Gershwin ME: A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007; 45: 659-665. (Pubitemid 46450617)
20. Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouilleres O, Poupon R: Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012, E-pub ahead of print. 21 Selmi C, Maria Papini A, Pugliese P, Claudia Alcaro M, Gershwin ME: Environmental pathways to autoimmune diseases: The cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci 2011; 7: 368-380.
21. Prince MI, Ducker SJ, James OF: Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut 2010; 59: 508-512.
22. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001; 33: 16-21. (Pubitemid 32016882)
23. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM: Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients. Hepatology 2005; 42: 1194-1202. (Pubitemid 43112687)
24. Corpechot C, Chretien Y, Chazouilleres O, Poupon R: Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 2010; 53: 162-169.
25. Selmi C, Cocchi CA, Zuin M, Gershwin ME: The chemical pathway to primary biliary cirrhosis. Clin Rev Allergy Immunol 2009; 36: 23-29.
26. Naiyanetr P, Butler JD, Meng L, Pfeiff J, Kenny TP, Guggenheim KG, Reiger R, Lam K, Kurth MJ, Ansari AA, Coppel RL, Lopez-Hoyos M, Gershwin ME, Leung PS: Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 2011; 37: 209-216.
27. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Matsuura E, Coppel RL, Gershwin ME: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: Identi fication of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174: 5874-5883. (Pubitemid 40593233)
28. Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME: Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004; 172: 6444-6452. (Pubitemid 38621254)
29. Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, van de Water J, Luketic V, Roche TE, Ansari AA, Coppel RL, Gershwin ME: Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 2003; 125: 1705-1713. (Pubitemid 37500435)
30. Kimura Y, Selmi C, Leung PS, Mao TK, Schauer J, Watnik M, Kuriyama S, Nishioka M, Ansari AA, Coppel RL, Invernizzi P, Podda M, Gershwin ME: Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005; 41: 55-63. (Pubitemid 40066383)
31. Leung PS, Coppel RL, Gershwin ME: Etiology of primary biliary cirrhosis: The search for the culprit. Semin Liver Dis 2005; 25: 327-336. (Pubitemid 41254580)
32. Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, Coppel RL, Gershwin ME: Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007; 179: 2651-2657.
33. Leung PS, Quan C, Park O, van de Water J, Kurth MJ, Nantz MH, Ansari AA, Coppel RL, Lam KS, Gershwin ME: Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003; 170: 5326-5332. (Pubitemid 36554768)
34. Leung PS, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, Miyakawa H, Norman GL, Lee W, Gershwin ME: Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis. Hepatology 2007; 46: 1436-1442. (Pubitemid 350155525)
35. Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS, Barsky D, Ansari AA, Coppel RL, Mackay IR, Gershwin ME: Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006; 27: 7-16. (Pubitemid 44279362)
36. Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, van De Water J, Nantz MH, Kurth MJ, Gershwin ME: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38: 1250-1257. (Pubitemid 37314834)
37. Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME: Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48: 531-540.
38. Wakabayashi K, Yoshida K, Leung PS, Moritoki Y, Yang GX, Tsuneyama K, Lian ZX, Hibi T, Ansari AA, Wicker LS, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME: Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol 2009; 155: 577-586.
39. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ: Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment. Hepatology 2006; 44: 1564-1571. (Pubitemid 44953661)
40. Corpechot C, Gaouar F, Chretien Y, Johanet C, Chazouilleres O, Poupon R: Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. J Hepatol 2012; 56: 218-224.
41. Bogdanos DP, Baum H, Vergani D, Burroughs AK: The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010; 29: 301-311.
42. Varyani FK, West J, Card TR: An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol 2011; 11: 95.
43. Hirschfield GM, Liu X, Han Y, Gorlov IP, Lu Y, Xu C, Chen W, Juran BD, Coltescu C, Mason AL, Milkiewicz P, Myers RP, Odin JA, Luketic VA, Speiciene D, Vincent C, Levy C, Gregersen PK, Zhang J, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA: Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 2010; 42: 655-657.
44. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
45. Invernizzi P: Human leukocyte antigen in primary biliary cirrhosis: An old story now reviving. Hepatology 2011; 54: 714-723.
46. Liu X, Invernizzi P, Lu Y, Kosoy R, Bianchi I, Podda M, Xu C, Xie G, Macciardi F, Selmi C, Lupoli S, Shigeta R, Ransom M, Lleo A, Lee AT, Mason AL, Myers RP, Peltekian KM, Ghent CN, Bernuzzi F, Zuin M, Rosina F, Borghesio E, Floreani A, Lazzari R, Niro G, Andriulli A, Muratori L, Muratori P, Almasio PL, Andreone P, Margotti M, Brunetto M, Coco B, Alvaro D, Bragazzi MC, Marra F, Pisano A, Rigamonti C, Colombo M, Marzioni M, Benedetti A, Fabris L, Strazzabosco M, Portincasa P, Palmieri VO, Tiribelli C, Croce L, Bruno S, Rossi S, Vinci M, Prisco C, Mattalia A, Toniutto P, Picciotto A, Galli A, Ferrari C, Colombo S, Casella G, Morini L, Caporaso N, Colli A, Spinzi G, Montanari R, Gregersen PK, Heathcote EJ, Hirschfield GM, Siminovitch KA, Amos CI, Gershwin ME, Seldin MF: Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42: 658-660.
47. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, Heneghan MA, Neuberger JM, Donaldson PT, Day DB, Ducker SJ, Muriithi AW, Wheater EF, Hammond CJ, Dawwas MF, Jones DE, Peltonen L, Alexander GJ, Sandford RN, Anderson CA: Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011; 43: 329-332.
48. Selmi C, Affronti A, Ferrari L, Invernizzi P: Immune-mediated bile duct injury: The case of primary biliary cirrhosis. World J Gastrointest Pathophysiol 2010; 1: 118-128.
49. Tanaka A, Invernizzi P, Ohira H, Kikuchi K, Nezu S, Kosoy R, Seldin MF, Gershwin ME, Takikawa H: Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort. Tissue Antigens 2011; 78: 65-68.
50. Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M: Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology 2012; 55: 506-511.
51. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME: Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485-492. (Pubitemid 39091897)
52. Mitchell MM, Lleo A, Zammataro L, Mayo MJ, Invernizzi P, Bach N, Shimoda S, Gordon S, Podda M, Gershwin ME, Selmi C, LaSalle JM: Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011; 6: 95-102.
53. McNally RJ, James PW, Ducker S, James OF: Seasonal variation in the patient diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology. Hepatology 2011; 54: 2099-2103.
54. Smyk DS, Rigopoulou EI, Lleo A, Abeles RD, Mavropoulos A, Billinis C, Invernizzi P, Bogdanos DP: Immunopathogenesis of primary biliary cirrhosis: An old wives' tale. Immun Ageing 2011; 8: 12.
55. Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y: Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology 2008; 48: 186-195. (Pubitemid 351975543)
56. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest 2010; 90: 835-843.
57. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis. Dig Dis Sci 2012; 57: 660-666.
58. Rong G, Zhong R, Lleo A, Leung PS, Bowlus CL, Yang GX, Yang CY, Coppel RL, Ansari AA, Cuebas DA, Worman HJ, Invernizzi P, Gores GJ, Norman G, He XS, Gershwin ME: Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology 2011; 54: 196-203.
59. Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, van de Water J, Gershwin ME: Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009; 49: 871-879.
60. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME: Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010; 52: 987-998.
61. Takahashi T, Miura T, Nakamura J, Yamada S, Yanagi M, Matsuda Y, Usuda H, Emura I, Tsuneyama K, He XS, Gershwin ME: Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology 2012; 55: 660-666.
62. Selmi C, Lleo A, Pasini S, Zuin M, Gershwin ME: Innate immunity and primary biliary cirrhosis. Curr Mol Med 2009; 9: 45-51.
63. Harada K, Shimoda S, Ikeda H, Chiba M, Hsu M, Sato Y, Kobayashi M, Ren XS, Ohta H, Kasashima S, Kawashima A, Nakanuma Y: Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3alpha in the pathogenesis of primary biliary cirrhosis. Liver Int 2011; 31: 245-253.
64. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y: Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157: 261-270.
65. Wu SJ, Yang YH, Tsuneyama K, Leung PS, Illarionov P, Gershwin ME, Chuang YH: Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011; 53: 915-925.
66. Bogdanos DP, Vergani D: Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol 2009; 36: 30-39.
67. Selmi C, Gershwin ME: Bacteria and human autoimmunity: The case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406-410. (Pubitemid 38803142)